Mosaic ImmunoEngineering (CPMV) Free Cash Flow (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Free Cash Flow of -$3550.0 for Q1 2026, up 87.8% year-over-year from -$1890.3 in Q1 2025, and up 87.38% quarter-over-quarter from -$28139.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Free Cash Flow (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$3550.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 87.8% year-over-year to -$3550.0; the TTM figure through Mar 2026 stood at -$85858.0 (up 52.06% YoY), while the FY2025 annual figure was -$111397.0, up 53.81% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$3550.0, up from -$28139.0 in the prior quarter.
- The five-year high for Free Cash Flow was -$3550.0 in Q1 2026, with the low at -$189719.0 in Q1 2022.
- The 5-year median for Free Cash Flow is -$96720.0 (2023), against an average of -$90806.0.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow jumped 88.19% in 2024, then slumped 67.89% in 2025.
- Mosaic ImmunoEngineering's Free Cash Flow stood at -$163492.0 in 2022, then surged by 40.84% to -$96720.0 in 2023, then surged by 78.58% to -$20717.0 in 2024, then slumped by 35.83% to -$28139.0 in 2025, then surged by 87.38% to -$3550.0 in 2026.
- Business Quant data shows CPMV's Free Cash Flow at -$3550.0 in Q1 2026, -$28139.0 in Q4 2025, and -$21822.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | -3,550.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,550.00 |
| Mar 31, 2026 | -3,550.00 |
| Dec 31, 2025 | -28,139.00 |
| Dec 31, 2025 | -28,139.00 |
| Sep 30, 2025 | -21,822.00 |
| Sep 30, 2025 | -21,822.00 |
| Jun 30, 2025 | -32,347.00 |
| Jun 30, 2025 | -32,347.00 |
| Mar 31, 2025 | -29,089.00 |
| Mar 31, 2025 | -29,089.00 |
| Dec 31, 2024 | -20,717.00 |
| Dec 31, 2024 | -20,717.00 |
| Sep 30, 2024 | -12,998.00 |
| Sep 30, 2024 | -12,998.00 |
| Jun 30, 2024 | -116,305.00 |
| Jun 30, 2024 | -116,305.00 |
| Mar 31, 2024 | -91,139.00 |
| Mar 31, 2024 | -91,139.00 |
| Dec 31, 2023 | -96,720.00 |
| Dec 31, 2023 | -96,720.00 |